• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Novasys Medical

Anonymous board for Novasys Medical
Replies
0
Views
6K
Anonymous
Replies
8
Views
10K
Anonymous
Replies
1
Views
5K
Anonymous